Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Emerging Technology
Roche's breast cancer CDx receives CE Mark
By
LabPulse.com staff writers
Roche has received the CE Mark for the first companion diagnostic (CDx) test to identify patients with HER2-low metastatic breast cancer who may be eligible for treatment with Enhertu.
April 10, 2024
FDA clears another blood-based TBI POC test
By
LabPulse.com staff writers
Abbott furthers its point-of-care (POC) assay for measuring traumatic brain injury biomarkers from whole blood.
April 1, 2024
Researchers map protein biomarkers in sepsis fight
By
Liz Carey
Swedish researchers are mapping patterns of protein biomarkers in sepsis that could be useful for simple blood tests in the emergency department, according to research to be presented at ECCMID 2024.
April 2, 2024
Eventually, an oral cancer diagnosis may be a lick away
By
Melissa Busch
The University of Birmingham in the U.K. will develop a new, noninvasive way to diagnose mouth cancer that has a sweet twist.
March 28, 2024
Metabolon releases integrated bioinformatics platform
By
Matt Limb
Metabolon has launched an integrated bioinformatics platform to aid metabolomics analysis in life sciences research.
March 12, 2024
FDA LDT oversight battle: Are we close?
By
Liz Carey
New directions in laboratory developed test (LDT) regulation appeared closer to final rule-making with the March 1 Office of Management and Budget (OMB) acceptance of the LDT final rule, pending regulatory review: a flurry of final rule-making thoughts.
March 6, 2024
Alamar Biosciences raises $100M in series C financing round
By
LabPulse.com staff writers
Precision proteomics company Alamar Biosciences has raised $100 million in an oversubscribed series C financing round, with a second close of an additional $28 million anticipated within the next 30 days.
February 27, 2024
Gold-enhanced nanopore sensors detect ovarian cancer biomarker in urine
By
Nick Paul Taylor
Nanopore sensors that use gold nanoparticles to capture certain peptides could enable the detection of ovarian cancer biomarkers in urine samples, according to a paper published in ACS Sensors.
February 14, 2024
FDA approves Abbott laboratory automation system
By
LabPulse.com staff writers
Abbott’s new laboratory automation system has received U.S. Food and Drug Administration (FDA) approval, the company announced in a statement.
December 14, 2023
Two new directions in Parkinson’s testing
By
Liz Carey
Two recent Parkinson’s announcements suggest a new biomarker test panel coming, as well as cell culture systems for studying Parkinson’s in the laboratory.
December 11, 2023
Self-assembling, multicellular biobots repair damaged tissue in injury model
By
Nick Paul Taylor
Self-assembling, multicellular biobots can traverse and fix damaged neural tissues in a simplified injury model, suggesting that the tiny machines could have biomedical applications.
December 7, 2023
Networks of wearable sensors capture body sounds to improve patient monitoring
By
Nick Paul Taylor
Researchers have developed soft, miniaturized wearable devices to continuously capture the sounds of breathing and other bodily functions.
November 16, 2023
Page 1 of 51
Next Page